02/07/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/07/2024

Jul 2, 2024, 05:00 | Insight
AlphaFold’s recent advancements and its potential impact on predictive medicine
AI in Precision Oncology  shared a post on X: "AIPO is excited to publish a…
Jul 2, 2024, 04:51 | Insight
Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH
ASH shared a post on X: "A new study in Blood Advances find that patients…
Jul 2, 2024, 04:32 | Blog
Zhe Huang: Thrilled to be selected for Best Poster for prostate cancer at PrevConf24
Science and Innovation at Cancer Research UK shared a post on X: "Congratulations to the…
Jul 2, 2024, 04:25 | OncoDaily Pulse
OncoDaily Party and Yvonne Award 2024 Photos - Part 2
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jul 2, 2024, 04:16 | Insight
Olivier Calvayrac: TT-derived drug-tolerant (DT) lung cancer cells are vulnerable to FTIs
Olivier Calvayrac, Research Scientist at the Toulouse Cancer Research Center, shared a post on X…
Jul 2, 2024, 03:57 | Blog
Runcie C.W. Chidebe: Tangible progress hinges on addressing the realities faced by LMICs
Runcie C.W. Chidebe shared a post on X: ““While the global financial injection of $600…
Jul 2, 2024, 03:16 | Blog
C. Jillian Tsai: A very thoughtful opinion piece on caveats of using TTMV-HPV DNA in oropharyngeal carcinoma
C. Jillian Tsai, Radiation Oncologist at Princess Margaret Cancer Centre, Toronto, Canada shared a post on…
Jul 2, 2024, 03:02 | Blog
Myriam Chalabi: Patients with stage 1c TNBC with high TILs have an excellent prognosis without chemo
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
Jul 2, 2024, 02:23 | Blog
Dinesh Pendharkar receives Times Now Inspiring Oncologist of India Recognition
Dinesh Pendharkar shared a post on LinkedIn: “Honored to be at Times Now event yesterday.…
Jul 2, 2024, 02:13 | Blog
Buvanes Tharmalingam: Recognition for Patient Group Capability Building Initiatives 
Buvanes Tharmalingam, Integrated Policy and Advocacy Specialist at Roche, shared on LinkedIn "Recognition for Patient…
All: 104 Posts: 91 - 100
Special Coverage